Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Chang

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|October 25, 2019
First hyperpolarized [2-<sup>13</sup>C]pyruvate MR studies of human brain metabolismBrian T Chung, Hsin-Yu Chen, Jeremy Gordon, et al.
Journal of Neuro-Oncology|October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Neuro-Oncology|December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshopJason T Huse, Max Wallace, Kenneth D Aldape, et al.
Neuro-Oncology|December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
JCI Insight|September 23, 2025
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastomaSixuan Pan, Kanish Mirchia, Emily Payne, et al.
Neuro-Oncology|May 27, 2026
Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science IntegrationYolanda Piña, Maxine Umeh Garcia, Adrienne Boire, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
The Lancet. Oncology|December 19, 2015
Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) groupIsabelle Thibault, Eric L Chang, Jason Sheehan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|October 25, 2019
First hyperpolarized [2-<sup>13</sup>C]pyruvate MR studies of human brain metabolismBrian T Chung, Hsin-Yu Chen, Jeremy Gordon, et al.
Journal of Neuro-Oncology|October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Neuro-Oncology|December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshopJason T Huse, Max Wallace, Kenneth D Aldape, et al.
Neuro-Oncology|December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
JCI Insight|September 23, 2025
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastomaSixuan Pan, Kanish Mirchia, Emily Payne, et al.
Neuro-Oncology|May 27, 2026
Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science IntegrationYolanda Piña, Maxine Umeh Garcia, Adrienne Boire, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
The Lancet. Oncology|December 19, 2015
Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) groupIsabelle Thibault, Eric L Chang, Jason Sheehan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Pageof 12